(Q35871881)

10 August 2017

1 reference

title

A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases (English)

1 reference

10 August 2017

main subject

cardiovascular disease

1 reference

Claudio Borghi

1

1 reference

10 August 2017

Stefano Bacchelli

series ordinal

2

1 reference

10 August 2017

Daniela Degli Esposti

series ordinal

3

1 reference

10 August 2017

Ettore Ambrosioni

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

Expert Opinion on Pharmacotherapy

10 August 2017

published in

1 reference

10 August 2017

volume

5

1 reference

10 August 2017

issue

9

1 reference

10 August 2017

page(s)

1965-1977

1 reference

The renin-angiotensin system in the twenty-first century

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1965

The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1965

Effects of sulphydryl- and non-sulphydryl-containing ACE inhibitors on left ventricular relaxation in the isolated guinea pig heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1965

Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1965

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1965

Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1965

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin: systematic overview of individual data from 96,712 randomized patients. Angiotensin-conve

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1965

Survival of myocardial infarction long-term evaluation (SMILE) study: rationale, design, organization, and outcome definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1965

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1965

Biochemical and clinical predictors of long-term outcome in patients with nonspecific chest pain and nondiagnostic electrocardiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.9.1965

10.1517/14656566.5.9.1965

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference